Detection of the Uveal Melanoma-Associated Mutation <i>GNAQ</i> Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology-Reference-Cited by-同舟云学术

Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology

Published:2023-11-03 Issue:45 Volume:95 Page:16692-16700
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Escalona-Noguero Carmen¹,Alarcón-Iniesta Hernán¹,López-Valls María¹,del Carpio Luis Paul²³,Piulats Josep M.²³,Somoza Álvaro¹⁴^ORCID,Sot Begoña¹⁵⁶^ORCID

Affiliation:

1. Fundación IMDEA Nanociencia, Campus Universitario de Cantoblanco, Madrid 28049, Spain

2. Medical Oncology Department, Institut Català d’Oncologia─ICO, L’Hospitalet de Llobregat, IDIBELL, Barcelona 08908, Spain

3. Cancer ImmunoTherapy (CIT) Group−iPROCURE, Bellvitge Biomedical Research Institute IDIBELL-OncoBell, L'Hospitalet de Llobregat, Barcelona 08908, Spain

4. Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), Madrid 28049, Spain

5. Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Unidad de Innovación Biomédica, Complutense 40, Madrid 28040, Spain

6. Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJ UAM), Madrid 28040, Spain

Funder

Comunidad de Madrid

Ministerio de Ciencia e Innovaci?n

Fundaci?n Cient?fica Asociaci?n Espa?ola Contra el C?ncer

Sociedad Espa?ola de Oncolog?a M?dica

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.3c03460

Reference28 articles.

1. Uveal melanoma: relatively rare but deadly cancer

2. Future perspectives of uveal melanoma blood based biomarkers

3. The genetics of uveal melanoma: current insights

4. GNAQ and GNA11 mutations in uveal melanoma

5. GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma